Leonardo Santana Novaes

Dr. Leonardo Santana Novaes


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Neuropharmacology
Verified
Journal Article
Closed access
LNLeonardo Santana Novaes
Leonardo Santana Novaes
NSNilton dos Santos
Nilton dos Santos
RBRafaela F.P. Batalhote
Rafaela F.P. Batalhote
MMMarília Brinati Malta
Marília Brinati Malta
RCRosana Camarini
Rosana Camarini
CMCarolina Munhoz
Carolina Munhoz

1 November 2018 in Neuroscience
Verified
Journal Article
Closed access
LNLeonardo Santana Novaes
Leonardo Santana Novaes
NSNilton dos Santos
Nilton dos Santos
GDGuilherme Dragunas
Guilherme Dragunas
JPJuliano Genaro Perfetto
Juliano Genaro Perfetto
JLJuan Carlos Leza
Juan Carlos Leza
CMCarolina Munhoz
Carolina Munhoz

1 December 2018 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
LNLeonardo Santana Novaes
Leonardo Santana Novaes
NSNilton dos Santos
Nilton dos Santos
JPJuliano Genaro Perfetto
Juliano Genaro Perfetto
KGKi Ann Goosens
Ki Ann Goosens
CMCarolina Munhoz
Carolina Munhoz

30 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NSNilton dos Santos
Nilton dos Santos
LNLeonardo Santana Novaes
Leonardo Santana Novaes
GDGuilherme Dragunas
Guilherme Dragunas
JRJennifer R. Rodrigues
Jennifer R. Rodrigues
WBWesley Brandão
Wesley Brandão
CMCarolina Munhoz
Carolina Munhoz
Multiple sclerosis (MS) is an autoimmune and neuroinflammatory disease characterized by demyelination of the Central Nervous System. Immune cells activation and release of pro-inflammatory cytokines play a crucial role in the disease modulation, decisively contributing to the neurodegeneration observed in MS and the experimental autoimmune encephalomyelitis (EAE), the widely used MS animal model. Synthetic glucocorticoids, commonly used to treat the MS attacks, have controversial effects on neuroinflammation and cognition. We sought to verify the influence of dexamethasone (DEX) on the EAE progression and on EAE-induced cognitive deficits. In myelin oligodendrocyte glycoprotein peptide (MOG35-55)-induced EAE female mice, treated once with DEX (50 mg/kg) or not, on the day of immunization, DEX decreased EAE-induced motor clinical scores, infiltrating cells in the spinal cord and delayed serum corticosterone peak. At the asymptomatic phase (8-day post-immunization), DEX did not protected from the EAE-induced memory consolidation deficits, which were accompanied by increased glucocorticoid receptor (GR) activity and decreased EGR-1 expression in the hippocampus. Blunting hippocampal GR genomic activation with DnGR vectors prevented DEX effects on EAE-induced memory impairment. These data suggest that, although DEX improves clinical signs, it decreases cognitive and memory capacity by diminishing neuronal activity and potentiating some aspects of neuroinflammation in EAE.

1 November 2011 in Brain Research
Verified
Journal Article
Closed access
LNLeonardo Santana Novaes
Leonardo Santana Novaes
SSSara J. Shammah-Lagnado
Sara J. Shammah-Lagnado

Verified
Journal Article
Open access
PDF file
TFThaina Maquedo Franco
Thaina Maquedo Franco
MTMariana Rosolen Tavares
Mariana Rosolen Tavares
LNLeonardo Santana Novaes
Leonardo Santana Novaes
CMCarolina Munhoz
Carolina Munhoz
JPJose Eduardo Peixoto-Santos
Jose Eduardo Peixoto-Santos
FWFrederick Wasinski
Frederick Wasinski
The kallikrein–kinin system is a versatile regulatory network implicated in various biological processes encompassing inflammation, nociception, blood pressure control, and central nervous system functions. Its physiological impact is mediated through G-protein-coupled transmembrane receptors, specifically the B1 and B2 receptors. Dopamine, a key catecholamine neurotransmitter widely distributed in the CNS, plays a crucial role in diverse physiological functions including motricity, reward, anxiety, fear, feeding, sleep, and arousal. Notably, the potential physical interaction between bradykinin and dopaminergic receptors has been previously documented. In this study, we aimed to explore whether B2R modulation in catecholaminergic neurons influences the dopaminergic pathway, impacting behavioral, metabolic, and motor aspects in both male and female mice. B2R ablation in tyrosine hydroxylase cells reduced the body weight and lean mass without affecting body adiposity, substrate oxidation, locomotor activity, glucose tolerance, or insulin sensitivity in mice. Moreover, a B2R deficiency in TH cells did not alter anxiety levels, exercise performance, or motor coordination in female and male mice. The concentrations of monoamines and their metabolites in the substantia nigra and cortex region were not affected in knockout mice. In essence, B2R deletion in TH cells selectively influenced the body weight and composition, leaving the behavioral and motor aspects largely unaffected.